Abstract

This study is designed to derive and psychometrically evaluate RESOLVE-P scores, and to derive score interpretation thresholds to demonstrate to regulators that the RESOLVE-P is appropriate to assess the severity of pediatric RSV signs/symptoms in future clinical trials.